Reversing Cellular Aging with SIRT3 Activation

#longevity #aging #enzymes

CCM Biosciences has developed compounds activating the SIRT3 enzyme, potentially reversing age-related cellular decline. These novel compounds, unlike previous attempts, overcome challenges in activating this "undruggable" enzyme by employing a new mechanism. The discovery offers hope for treating Alzheimer's, Parkinson's, and other age-related diseases, currently undergoing animal testing and soon to enter clinical trials. This breakthrough builds upon decades of research focused on sirtuin enzymes and their role in longevity, representing a significant advancement in the field of age-related disease treatment. The potential economic impact of even a one-year lifespan increase is estimated to be over $10 trillion globally.

Like and subscribe for more AI news and insights!